✦ LIBER ✦

Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory

✍ Scribed by Yoshihiko Hirao, Seiichiro Ozono, Hitoshi Momose…

Book ID: 120777495
Publisher: Springer
Year: 1994
Tongue: English
Weight: 441 KB
Volume: 35
Category: Article
ISSN: 0344-5704
DOI: 10.1007/BF00686917

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravesical epirubicin in the prophylax

Intravesical epirubicin in the prophylaxis of superficial bladder cancer

✍ F. Şengör; M. Beysel; K. Erdoĝan; A. Erol; D. Tuzluoĝlu 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 248 KB

BCG versus epirubicin in the prophylaxis

BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours: Results of a prospective randomized study using modified treatment schemes

✍ M. D. Melekos; I. Zarakovitis; K. Dandinis; E. Fokaefs; H. Chionis; H. Dauaher; 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 650 KB

TRANSURETHRAL RESECTION WITH PERIOPERATI

TRANSURETHRAL RESECTION WITH PERIOPERATIVE INSTILLATION OF INTERFERON-alpha OR EPIRUBICIN FOR THE PROPHYLAXIS OF RECURRENT PRIMARY SUPERFICIAL BLADDER CANCER: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY-FINNBLADDER III

✍ RAJALA, PERTTI; LIUKKONEN, TAPANI; RAITANEN, MIKA; RINTALA, ERKKI; KAASINEN, EER 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 401 KB

Intravesical 4′-epi-doxorubicin(epirubic

Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

✍ Michael D. Melekos; Heracles S. Chionis; George S. Paranychianakis; Houssam H. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and

595 PROSPECTIVE, RANDOMIZED, COMPARATIVE

595 PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF HIGH DOSE INTRAVESICAL EPIRUBICIN VERSUS BCG FOR PROPHYLAXIS IN INTERMEDIATE RISK SUPERFICIAL BLADDER TUMORS

✍ G. Moutzouris; M. Lykourinas; D. Malovrouvas; C. Tsolos; E. Michail; I. Gezerlis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 320 KB

The influence of review pathology on stu

The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial

✍ J. A. WITJES; L. A. L. M. KIEMENEY; H. E. SCHAAFSMA; F. M. J. DEBRUYNE; The Memb 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB